Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease (DIVERSITY LTE)
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Crohn's Disease
Sponsor: Galapagos NV
Terminated
development program for filgotinib for participants with Crohn's disease has been stopped
Other terminated trials from Galapagos NV
- Inflammatory Bowel Disease · Phase PHASE2 · Oct 2023
- Ulcerative Colitis · Phase PHASE3 · Oct 2023
- Autosomal Dominant Polycystic Kidney Disease · Phase PHASE2 · Apr 2023
- Primary Sjögren Syndrome · Phase PHASE2 · Dec 2021
- Systemic Lupus Erythematosus · Phase PHASE1 · Oct 2021
More terminations from Galapagos NV
A PHASE3 clinical study on Crohn's Disease, this trial is terminated or withdrawn. The trial is conducted by Galapagos NV and has accumulated 68 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
68 versions recorded-
Mar 2026 — Present [monthly]
Terminated PHASE3
-
Dec 2025 — Mar 2026 [monthly]
Terminated PHASE3
-
Nov 2025 — Dec 2025 [monthly]
Terminated PHASE3
-
Sep 2025 — Nov 2025 [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
▶ Show 63 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Terminated PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE3
Status: Enrolling By Invitation → Terminated
-
Feb 2023 — Sep 2023 [monthly]
Enrolling By Invitation PHASE3
-
May 2022 — Feb 2023 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2022 — May 2022 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2022 — Apr 2022 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2021 — Jan 2022 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2021 — Nov 2021 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE3
-
May 2021 — Jun 2021 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2021 — May 2021 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2021 — Apr 2021 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2021 — Mar 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2020 — Dec 2020 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2020 — Oct 2020 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2020 — Sep 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2020 — Aug 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Enrolling By Invitation PHASE3
-
May 2020 — Jun 2020 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2020 — May 2020 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2020 — Apr 2020 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2020 — Mar 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2020 — Feb 2020 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2019 — Jan 2020 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2019 — Dec 2019 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2019 — Nov 2019 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2019 — Sep 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2019 — Aug 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2019 — Jul 2019 [monthly]
Enrolling By Invitation PHASE3
-
May 2019 — Jun 2019 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2019 — May 2019 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2019 — Apr 2019 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2019 — Feb 2019 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2018 — Jan 2019 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2018 — Dec 2018 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2018 — Oct 2018 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2018 — Sep 2018 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2018 — Aug 2018 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation PHASE3
Status: Recruiting → Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Apr 2018 — May 2018 [monthly]
Recruiting PHASE3
-
Mar 2018 — Apr 2018 [monthly]
Recruiting PHASE3
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE3
-
Jan 2018 — Feb 2018 [monthly]
Recruiting PHASE3
-
Dec 2017 — Jan 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE3
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE3
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE3
-
Jun 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Galapagos NV
- Gilead Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Afula, Israel , Ageo-shi, Japan , Ahmedabad, India , Alkmaar, Netherlands , Amiens, France , Amsterdam, Netherlands , Annapolis, United States , Antwerp, Belgium , Apeldoorn, Netherlands , Arlington, United States and 374 more locations